ニュース

最新ニュース

Sequana Medical announces positive interim data from North American pivotal alfapump® study (POSEIDON)

16th 11月 2020

Sequana Medical announces strong interim results from RED DESERT alfapump® DSR study and provides business update

ACTICOR BIOTECH ANNOUNCES THE SUCCESS OF THE FIRST PHASE OF ITS ACTIMIS STUDY WITH GLENZOCIMAB IN PATIENTS WITH ACUTE ISCHEMIC STROKE

ジェイファーマ株式会社総額 17 億 4 千 6 百万円の資金調達完了

J-Pharma Raises 1,746 million JPY in Funding

SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 19.0 MILLION IN AN EQUITY PLACEMENT

Sequana Medical announces first patient enrolled in RED DESERT – REpeated Dose alfapump® DSR study for Treatment of diuretic-resistant heart failure patients

Sequana Medical appoints leading experts as Heart Failure Scientific Advisors

Sequana Medical announces unconditional IDE approval from U.S. FDA to start alfapump® pivotal study (POSEIDON)

11
12
13
14
15